Compound Monograph

Loganic Acid

Terpenoids Iridoids Natural (plant-derived)

Loganic acid is a bitter iridoid glucoside of cornelian cherry, bogbean and snowberry — best understood as the immediate biosynthetic precursor of loganin, one methyl group short of it. Loganic acid O-methyltransferase (LAMT) converts it to loganin en route to secologanin and the great iridoid/alkaloid lineage. As a therapeutic isolate its data are thin and entirely preclinical (antioxidant and anti-atherosclerotic rodent work), with poor oral bioavailability (~3-6% in rats) and no human trials.

Sources · 7

Where Does It Come From?

Loganic Acid is a naturally occurring iridoid glucoside (monoterpenoid; carboxylic-acid precursor of loganin), found in Cornelian cherry fruit, Cornelian cherry fruit — shan zhu yu, Bogbean and 4 other sources. It is well tolerated orally (low toxicity).

Also found in
Bogbean Monograph coming soon
Clearing-nut tree seeds Monograph coming soon
Cornelian cherry fruit Monograph coming soon
Cornelian cherry fruit — shan zhu yu Monograph coming soon
Snowberry Monograph coming soon
Various Cornaceae, Menyanthaceae and Loganiaceae Monograph coming soon

Concentration

Content by Source

Concentrations not reported. No percent-dry-weight or mg/g figures have been published for this compound in its source plants.

Loganic Acid at a Glance

Loganic acid is a bitter iridoid glucoside — a small, water-soluble monoterpenoid found in cornelian cherry, bogbean, snowberry and other iridoid-bearing plants. Chemically it is one methyl group short of loganin: loganin is simply the methyl ester of loganic acid’s carboxylic-acid group.

That relationship is the whole point of the molecule. Loganic acid’s significance is overwhelmingly biosynthetic — it is the immediate precursor that the enzyme loganic acid O-methyltransferase (LAMT) converts to loganin, the last common intermediate before the pathway branches toward the monoterpene indole alkaloids and the secoiridoids 1Reference 1Jędrzejewski M et al. · 2023The reaction mechanism of loganic acid methyltransferase: a molecular dynamics simulation and quantum mechanics studyView study →.

As a therapeutic isolate in its own right, loganic acid is data-thin and entirely preclinical. A small cluster of antioxidant and anti-atherosclerotic studies — mostly on cornelian-cherry-derived loganic acid in rodents — is the extent of the direct pharmacology; there are no human trials of the isolate, and its oral bioavailability is poor (roughly 3-6% in rats), which limits how far cell and high-dose findings translate 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →. This page stays deliberately short and states plainly where the evidence stops.

Loganic Acid, Precursor of Loganin

The reason to have a page on loganic acid at all is its position one step upstream of loganin in the iridoid pathway. The route runs geraniol → … → loganic acid → loganin → secologanin, and the loganic-acid → loganin step is a single, well-characterised methylation.

Loganic acid O-methyltransferase (LAMT) transfers a methyl group from S-adenosyl-methionine (SAM) to the C-11 carboxyl group of loganic acid, producing the methyl ester — loganin — and SAH 1Reference 1Jędrzejewski M et al. · 2023The reaction mechanism of loganic acid methyltransferase: a molecular dynamics simulation and quantum mechanics studyView study →. Loganin is then cleaved by secologanin synthase (a cytochrome P450) to give secologanin, the hinge from which two enormous families of natural products diverge: the monoterpene indole alkaloids (strychnine, quinine, the Catharanthus anticancer dimers) and the secoiridoids (gentiopicroside and, further on, oleuropein). Loganic acid sits immediately before that machinery — it is the substrate LAMT acts on, the point at which the free acid becomes the methyl ester that the rest of the pathway consumes.

This is why loganic acid is interesting out of proportion to its own pharmacology: like its sibling loganin, most of the biological “activity” of this skeleton in nature is expressed only after it has been transformed into something else. In cornelian cherry and other sources loganic acid also simply accumulates as a bitter iridoid glucoside alongside loganin and morroniside, contributing to the fruit’s bitter, astringent character. Its own measured pharmacology — the antioxidant and anti-atherosclerotic signal below — is real but modest, and human data are absent.

What It's Used For

Loganic acid’s direct evidence base is small, consistent and entirely preclinical. The load-bearing caveats are the compound-page discipline: no human trials of the isolate, and poor oral bioavailability means in-vitro and high-dose rodent potency overstate what an oral dose delivers 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →.

A genuine antioxidant/redox signal (isolate):cornelian-cherry loganic acid restored antioxidant-enzyme activity and glutathione and cut oxidative-stress markers in the leukocytes of diabetic rats — without lowering blood glucose — and a Strychnos isolate scavenges radicals and is cytoprotective in vitro 2,5Reference 2Dzydzan O et al. · 2020AnimalLoganic acid, an iridoid glycoside extracted from Cornus mas L. fruits, reduces carbonyl/oxidative stress biomarkers in plasma and restores antioxidant balance in leukocytes of rats with streptozotocin-induced diabetes mellitusView study →Reference 5Abirami A et al. · 2022Antioxidant and cytoprotective properties of loganic acid isolated from seeds of Strychnos potatorum L. against heavy metal induced toxicity in PBMC modelView study →.
An anti-atherosclerotic / cardiometabolic thread (isolate, rabbit):loganic acid modestly improved diet-induced dyslipidaemia and atherosclerosis, raised PPARα expression, lowered TNFα/IL-6, and improved the L-arginine/ADMA ratio and eNOS signalling — though the co-tested anthocyanins were generally more potent 3,4Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →Reference 4Sozański T et al. · 2019The iridoid loganic acid and anthocyanins from the cornelian cherry (Cornus mas L.) fruit increase the plasma L-arginine/ADMA ratio and decrease levels of ADMA in rabbits fed a high-cholesterol dietView study →.
The honest headline:significance is largely biosynthetic (the LAMT substrate that becomes loganin 1Reference 1Jędrzejewski M et al. · 2023The reaction mechanism of loganic acid methyltransferase: a molecular dynamics simulation and quantum mechanics studyView study →); the isolate pharmacology is preclinical only, oral bioavailability is ~3-6% in rats 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →, and human exposure is through the whole fruit, not the purified acid.
Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. There are no human isolate data, so scores stay low by design.

Mechanisms

Target / pathwayEffectRelevant to
Catalase, glutathione peroxidase/reductase; GSH; ROS & lipid peroxidationantioxidant enzymes and GSH ↑; ROS/LPO ↓ (diabetic-rat leukocytes)
antioxidant / redox
DPPH, superoxide, hydroxyl radicalsdirect scavenging; cytoprotection in PBMCs
antioxidant (in vitro)
PPARαexpression increased
anti-atherosclerotic / lipid
TNFα, IL-6 (and IL-1β)pro-inflammatory cytokines decreased
anti-inflammatory
DDAH1 / ADMA; eNOSADMA ↓, L-arg/ADMA ratio ↑, aortic eNOS mRNA ↑
endothelial / nitric oxide
TLR4 / p38 MAPKsuppressed
diabetic cardiomyopathy
Loganic acid O-methyltransferase (LAMT) → loganinC-11 carboxyl O-methylation (in planta)
the precursor role — not human pharmacology

The reproduced core is an antioxidant/anti-inflammatory program shared with its sibling loganin. The LAMT row is plant biochemistry — the reason the molecule matters — but off the human-pharmacology axis.

Pharmacokinetics

Loganic acid is a hydrophilic iridoid glucoside with poor oral bioavailability. A validated LC-MS/MS pharmacokinetic study in rats reported an absolute oral bioavailability of only ~2.71-5.58% across a 50-150 mg/kg oral dose range (against a 2 mg/kg intravenous reference) 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →. This is the standard iridoid-glucoside caveat and mirrors its sibling loganin: micromolar in-vitro potency and high rodent doses substantially overstate what an oral human exposure would deliver, and the molecule is better read as a poorly-absorbed marker of a whole-fruit effect than as a stand-alone oral drug 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →.

Clinical Trials

There are no controlled trials of isolated loganic acid. Any human footprint is entirely indirect, through the whole cornelian-cherry fruit and other iridoid-bearing plants, where loganic acid is one iridoid among many rather than the tested agent.

CompletedPlannedTerminatedPreclinical
—(none, isolate)——Small(antioxidant-led; anti-atherosclerotic, diabetic-cardiomyopathy)

Last checked: July 2026.

Isolate vs. Plant Studies

Unusually for a data-thin molecule, loganic acid’s small pharmacology is mostly isolate work — the diabetic-rat antioxidant study used loganic acid purified from Cornus mas 2Reference 2Dzydzan O et al. · 2020AnimalLoganic acid, an iridoid glycoside extracted from Cornus mas L. fruits, reduces carbonyl/oxidative stress biomarkers in plasma and restores antioxidant balance in leukocytes of rats with streptozotocin-induced diabetes mellitusView study →, the atherosclerosis and ADMA studies dosed the isolated acid against an anthocyanin comparator 3,4Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →Reference 4Sozański T et al. · 2019The iridoid loganic acid and anthocyanins from the cornelian cherry (Cornus mas L.) fruit increase the plasma L-arginine/ADMA ratio and decrease levels of ADMA in rabbits fed a high-cholesterol dietView study →, and the radical-scavenging work used loganic acid isolated from Strychnos potatorum 5Reference 5Abirami A et al. · 2022Antioxidant and cytoprotective properties of loganic acid isolated from seeds of Strychnos potatorum L. against heavy metal induced toxicity in PBMC modelView study →. That is an attributional strength: these are loganic acid’s own measured effects, not an extract’s. The weakness is translational — poor oral bioavailability (~3-6% in rats) means isolate potency does not transfer cleanly to an achievable oral dose 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study → — and comparative — where a whole fraction was co-tested, the anthocyanins usually did more of the work than the iridoid 3Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →. There is no human isolate evidence at all; real-world exposure is to the whole cornelian-cherry fruit and similar plants.

Prevalence in Nature

Loganic acid is a widespread but usually minor iridoid glucoside across iridoid-bearing lineages. Its best-characterised source is cornelian cherry — both European cornelian cherry (Cornus mas), the subject of most of the isolate pharmacology 2,3,4Reference 2Dzydzan O et al. · 2020AnimalLoganic acid, an iridoid glycoside extracted from Cornus mas L. fruits, reduces carbonyl/oxidative stress biomarkers in plasma and restores antioxidant balance in leukocytes of rats with streptozotocin-induced diabetes mellitusView study →Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →Reference 4Sozański T et al. · 2019The iridoid loganic acid and anthocyanins from the cornelian cherry (Cornus mas L.) fruit increase the plasma L-arginine/ADMA ratio and decrease levels of ADMA in rabbits fed a high-cholesterol dietView study →, and the Chinese cornelian cherry (Cornus officinalis, shan zhu yu), where it accumulates alongside loganin and morroniside. Beyond Cornus it occurs in bogbean (Menyanthes trifoliata) and snowberry (Symphoricarpos), in cat’s claw (Uncaria tomentosa) as one of the vine’s iridoids, and in clearing-nut (Strychnos potatorum) seeds 5Reference 5Abirami A et al. · 2022Antioxidant and cytoprotective properties of loganic acid isolated from seeds of Strychnos potatorum L. against heavy metal induced toxicity in PBMC modelView study →.

Absolute content is rarely reported as a clean % dry weight and varies with species, plant part and ripeness, so a reliable cross-source concentration ranking does not exist here and is tracked as a gap rather than asserted.

Major Natural Sources

Source (Botanical)PartNotes
Cornelian cherry (Cornus mas)FruitSource for most of the isolate pharmacology 2,3,4Reference 2Dzydzan O et al. · 2020AnimalLoganic acid, an iridoid glycoside extracted from Cornus mas L. fruits, reduces carbonyl/oxidative stress biomarkers in plasma and restores antioxidant balance in leukocytes of rats with streptozotocin-induced diabetes mellitusView study →Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →Reference 4Sozański T et al. · 2019The iridoid loganic acid and anthocyanins from the cornelian cherry (Cornus mas L.) fruit increase the plasma L-arginine/ADMA ratio and decrease levels of ADMA in rabbits fed a high-cholesterol dietView study →
Cornelian cherry (Cornus officinalis)Fruit (shan zhu yu)Co-occurs with loganin and morroniside
Bogbean (Menyanthes trifoliata)LeafA bitter iridoid of the herb
Snowberry (Symphoricarpos spp.)Fruit/plantReported iridoid constituent
Cat’s claw (Uncaria tomentosa)Bark/vineOne of the iridoid constituents
Clearing-nut (Strychnos potatorum)SeedIsolation source for the antioxidant study 5Reference 5Abirami A et al. · 2022Antioxidant and cytoprotective properties of loganic acid isolated from seeds of Strychnos potatorum L. against heavy metal induced toxicity in PBMC modelView study →

Discovery & Synthesis

Loganic acid is an iridoid of the loganin pathway, and its identity is bound to that of loganin itself — the name traces through loganin to the Loganiaceae, the plant family named after the botanist James Logan. It was recognised as the immediate carboxylic-acid precursor of loganin (loganin being its C-11 methyl ester) through the mid-twentieth-century natural-product and radiotracer chemistry that mapped the geraniol → loganic acid → loganin → secologanin route; the enzyme responsible for the methylation step, loganic acid O-methyltransferase (LAMT), has since been characterised in strictosidine-producing plants and studied down to its reaction mechanism 1Reference 1Jędrzejewski M et al. · 2023The reaction mechanism of loganic acid methyltransferase: a molecular dynamics simulation and quantum mechanics studyView study →. Total synthesis of the loganin/iridoid skeleton has been reported in the natural-product literature, but synthesis is not the supply route: research-grade loganic acid is obtained by extraction from iridoid-rich plants, chiefly cornelian-cherry fruit, where its glucoside chemistry makes isolation more practical than total synthesis.

Patents: not yet researched.

Toxicity & Safety

Loganic acid reads as a low-toxicity iridoid glucoside. It is a natural constituent of cornelian cherry, an edible fruit eaten and used medicinally for centuries, and preclinical studies report no acute-toxicity signal at the doses used 2,3Reference 2Dzydzan O et al. · 2020AnimalLoganic acid, an iridoid glycoside extracted from Cornus mas L. fruits, reduces carbonyl/oxidative stress biomarkers in plasma and restores antioxidant balance in leukocytes of rats with streptozotocin-induced diabetes mellitusView study →Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →. The rating stays off “none” for evidentiary reasons: there is no comprehensive isolate toxicology package (no definitive LD50, genotoxicity or repeat-dose organ-toxicity dataset) for pure loganic acid, and its poor oral bioavailability means real-world isolate exposure is limited 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →.

Safety at a Glance
Low / no toxicity
  • A constituent of an edible fruit. Loganic acid occurs in cornelian cherry, long eaten and used medicinally, with no acute-toxicity signal in the rodent/rabbit studies 2,3Reference 2Dzydzan O et al. · 2020AnimalLoganic acid, an iridoid glycoside extracted from Cornus mas L. fruits, reduces carbonyl/oxidative stress biomarkers in plasma and restores antioxidant balance in leukocytes of rats with streptozotocin-induced diabetes mellitusView study →Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →.
  • Real-world exposure is whole-plant and low. People meet loganic acid as a fruit/herb constituent, not as a concentrated isolate, and its oral absorption is poor (~3-6% in rats) 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →.
  • No comprehensive isolate toxicology. No definitive LD50, genotoxicity or repeat-dose package for the pure compound; safety is inferred from the whole fruit, not established for the molecule.
  • In-vitro potency overreads oral exposure. Poor bioavailability limits how far cell/high-dose findings translate, and interaction data are uncharacterised rather than absent 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →.

Reproductive note (prose only). No dedicated reproductive- or developmental-toxicity dataset exists for isolated loganic acid. Any pregnancy or lactation caution around loganic-acid-containing plants (cornelian cherry, bogbean, cat’s claw and the alkaloid-associated Strychnos) belongs to the source herb and its actives, and is a decision made on the herb or product page where intake is decided — not on this molecule page.

Dosage

There is no established or recommended human dose for isolated loganic acid — it has never been given to people as an isolate for therapy. Cited figures are preclinical research doses: micromolar concentrations in vitro, and roughly tens of mg/kg in rodents (e.g. 20 mg/kg orally in the rabbit atherosclerosis work 3Reference 3Sozański T et al. · 2016Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammationView study →), typically above what an oral dose delivers given poor oral bioavailability (~2.71-5.58% in rats) 6Reference 6Wang P et al. · 2024AnimalA simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysisView study →. Human intake is indirect, through the whole cornelian-cherry fruit and other iridoid-bearing plants, where loganic acid is one iridoid among many rather than a dosed drug. These are doses studied in research and are not a personal recommendation.

References

  1. Jędrzejewski M, et al. (2023). The reaction mechanism of loganic acid methyltransferase: a molecular dynamics simulation and quantum mechanics study. Molecules. https://pubmed.ncbi.nlm.nih.gov/37570737/
  2. Dzydzan O, et al. (2020). Loganic acid, an iridoid glycoside extracted from Cornus mas L. fruits, reduces carbonyl/oxidative stress biomarkers in plasma and restores antioxidant balance in leukocytes of rats with streptozotocin-induced diabetes mellitus. Life (Basel). https://pubmed.ncbi.nlm.nih.gov/33333730/
  3. Sozański T, et al. (2016). Iridoid-loganic acid versus anthocyanins from the Cornus mas fruits (cornelian cherry): common and different effects on diet-induced atherosclerosis, PPARs expression and inflammation. Atherosclerosis. https://pubmed.ncbi.nlm.nih.gov/27744131/
  4. Sozański T, et al. (2019). The iridoid loganic acid and anthocyanins from the cornelian cherry (Cornus mas L.) fruit increase the plasma L-arginine/ADMA ratio and decrease levels of ADMA in rabbits fed a high-cholesterol diet. Phytomedicine. https://pubmed.ncbi.nlm.nih.gov/30599888/
  5. Abirami A, et al. (2022). Antioxidant and cytoprotective properties of loganic acid isolated from seeds of Strychnos potatorum L. against heavy metal induced toxicity in PBMC model. Drug and Chemical Toxicology. https://pubmed.ncbi.nlm.nih.gov/31645139/
  6. Wang P, et al. (2024). A simple and sensitive LC-MS/MS method for the determination of loganic acid in rat plasma and its pharmacokinetic analysis. Biomedical Chromatography. https://pubmed.ncbi.nlm.nih.gov/38956830/
  7. Ding X, et al. (2025). Loganic acid ameliorates diabetic cardiomyopathy via suppressing TLR4/p38 MAPK signaling-mediated oxidative stress and inflammation. Journal of Clinical Biochemistry and Nutrition. https://pubmed.ncbi.nlm.nih.gov/41312011/